Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
Earnings for Invitae Corporation (NVTA)
Earnings in 2022 (TTM): $-3,151,197,000
According to Invitae Corporation's latest financial reports the company's current earnings (TTM) are $-3,151,197,000. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Invitae Corporation
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2022 | $-3,151,197,000 | $-3,106,293,000 |
| 2021 | $-415,863,000 | $-379,006,000 |
| 2020 | $-714,270,000 | $-608,870,000 |
| 2019 | $-260,415,000 | $-241,965,000 |
| 2018 | $-132,155,000 | $-129,355,000 |
| 2017 | $-125,236,000 | $-123,380,000 |
| 2016 | $-100,256,000 | $-100,256,000 |
| 2015 | $-89,782,000 | $-89,782,000 |
| 2014 | $-47,668,000 | $-47,668,000 |
| 2013 | $-24,838,000 | $-24,838,000 |
| 2012 | $-8,602,000 | $-8,602,000 |